📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers. (2017)

First Author: England RM

Attributed to: Bar-Coded Biomaterials - Designing Self-Authenticating Medicines funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2016.12.034

PubMed Identifier: 28043863

Publication URI: http://europepmc.org/abstract/MED/28043863

Type: Journal Article/Review

Volume: 247

Parent Publication: Journal of controlled release : official journal of the Controlled Release Society

ISSN: 0168-3659